Paulson Wealth Management Inc. Amgen Inc Transaction History

Paulson Wealth Management Inc.

$341 Million
Q2 2024

A detailed history of Paulson Wealth Management Inc. transactions in Amgen Inc stock. As of the latest transaction made, Paulson Wealth Management Inc. holds 1,906 shares of AMGN stock, worth $605,116. This represents 0.17% of its overall portfolio holdings.

Number of Shares

1,906

Previous 1,930 1.24%

Holding current value

$605,116

Previous $548,000 8.58%

% of portfolio

0.17%

Previous 0.16%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$262.75 - $319.31 $6,306 - $7,663	-24 Reduced 1.24%	1,906 $595,000
Q1 2024 May 03, 2024	BUY	$268.87 - $324.56 $7,797 - $9,412	29 Added 1.53%	1,930 $548,000
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $269,507 - $304,036	-1,054 Reduced 35.67%	1,901 $547,000
Q3 2023 Nov 01, 2023	BUY	$218.65 - $271.46 $220,836 - $274,174	1,010 Added 51.93%	2,955 $794,000
Q2 2023 Aug 01, 2023	BUY	$214.27 - $253.37 $150,417 - $177,865	702 Added 56.48%	1,945 $431,000
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $42,900 - $52,288	190 Added 18.04%	1,243 $300,000
Q4 2022 Jan 26, 2023	BUY	$229.03 - $291.01 $241,168 - $306,433	1,053 New	1,053 $0
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $3,922 - $4,364	-17 Reduced 1.29%	1,305 $318,000
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $17,980 - $19,890	82 Added 6.61%	1,322 $320,000
Q4 2021 Jan 28, 2022	BUY	$198.88 - $227.6 $246,611 - $282,224	1,240 New	1,240 $279,000
Q4 2020 Feb 05, 2021	SELL	$216.38 - $257.67 $254,895 - $303,535	-1,178 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$234.65 - $260.95 $276,417 - $307,399	1,178 New	1,178 $299,000

Others Institutions Holding AMGN

# of Institutions

3,056

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $170B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paulson Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Paulson Wealth Management Inc. with notifications on news.

Account

Paulson Wealth Management Inc. Amgen Inc Transaction History